|
| Variables | Overall () | Ischemic stroke () | No stroke () | value |
|
| Age (years) | 59.68 (35.18-77.30) | 60.65 (38.72-77.30) | 58.44 (35.18-75.72) | 0.258 |
| Gender (male) | 47 (83.9%) | 22 (78.6%) | 25 (89.3%) | 0.275 |
| Systolic blood pressure (mmHg) | 125.00 (83.00-173.00) | 124.50 (90.00-173.00) | 126.50 (83.00-158.00) | 0.491 |
| Diastolic blood pressure (mmHg) | 75.50 (44.00-108.00) | 72.00 (50.00-108.00) | 81.00 (44.00-107.00) | 0.161 |
| Etiology of liver diseases |
| Hepatitis B virus infection | 23 (41.1%) | 10 (35.7%) | 13 (46.4%) | 0.415 |
| Hepatitis C virus infection | 1 (1.8%) | 1 (3.6%) | 0 (0.0%) | 0.313 |
| Alcohol abuse | 35 (62.5%) | 18 (64.3%) | 17 (60.7%) | 0.783 |
| Drug related | 6 (10.7%) | 4 (14.3%) | 2 (7.1%) | 0.388 |
| Budd-Chiari syndrome | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | NA |
| Autoimmune liver diseases | 1 (1.8%) | 0 (0.0%) | 1 (3.6%) | 0.313 |
| Clinical presentations at admission |
| Hepatic encephalopathy | 2 (3.6%) | 1 (3.6%) | 1 (3.6%) | 1.000 |
| Acute gastrointestinal bleeding | 13 (23.2%) | 7 (25.0%) | 6 (21.4%) | 0.752 |
| Ascites (no/mild/moderate-severe) | 27 (48.2%)/14 (25.0%)/15 (26.8%) | 15 (53.6%)/6 (21.4%)/7 (25.0%) | 12 (42.9%)/8 (28.6%)/8 (28.6%) | 0.710 |
| History |
| History of venous thrombus | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | NA |
| History of hematological diseases | 1 (1.8%) | 1 (3.6%) | 0 (0.0%) | 0.313 |
| History of diabetes mellitus | 12 (21.4%) | 8 (28.6%) | 4 (14.3%) | 0.193 |
| History of arterial hypertension | 13 (23.2%) | 10 (35.7%) | 3 (10.7%) | 0.027 |
| History of smoking | 39 (69.6%) | 20 (71.4%) | 19 (67.9%) | 0.771 |
| History of cardiac diseases | 8 (14.3%) | 5 (17.9%) | 3 (10.7%) | 0.445 |
| Laboratory tests |
| Red blood cell (1012/L) | 3.52 (1.15-5.20) | 3.34 (1.15-5.20) | 3.69 (1.74-5.08) | 0.456 |
| Hemoglobin (g/L) | 109.00 (37.00-174.00) | 102.00 (37.00-174.00) | 110.50 (58.00-156.00) | 0.812 |
| White blood cell (109/L) | 4.25 (1.30-22.70) | 4.70 (1.30-22.70) | 4.05 (1.30-20.80) | 0.063 |
| Platelet (109/L) | 84.50 (37.00-423.00) | 88.00 (37.00-377.00) | 75.00 (37.00-423.00) | 0.961 |
| Total bilirubin (μmol/L) | 24.25 (5.70-132.70) | 25.30 (5.70-132.70) | 24.15 (6.60-47.00) | 0.718 |
| Direct bilirubin (μmol/L) | 9.55 (2.00-78.20) | 9.30 (2.00-78.20) | 9.60 (2.50-27.00) | 0.961 |
| Indirect bilirubin (μmol/L) | 12.45 (3.60-76.00) | 12.60 (3.60-76.00) | 12.35 (4.10-27.70) | 0.967 |
| Albumin (g/L) | 32.55 (22.10-46.20) | 30.75 (22.10-44.50) | 33.95 (24.50-46.20) | 0.201 |
| Alanine aminotransferase (U/L) | 24.79 (7.53-176.68) | 21.66 (7.74-176.68) | 25.59 (7.53-140.00) | 0.793 |
| Aspartate aminotransferase (U/L) | 33.94 (9.74-166.49) | 34.22 (9.74-143.00) | 33.94 (13.94-166.49) | 0.857 |
| Alkaline phosphatase (U/L) | 98.86 (28.83-337.00) | 93.60 (28.83-337.00) | 102.83 (52.28-337.00) | 0.481 |
| γ-Glutamyl transpeptidase (U/L) | 60.87 (10.00-1779.18) | 69.50 (10.00-1779.18) | 56.00 (10.93-552.26) | 0.611 |
| Blood urea nitrogen (mmol/L) | 5.62 (2.96-47.25) | 5.81 (3.52-47.25) | 5.38 (2.96-20.15) | 0.502 |
| Serum creatinine (μmol/L) | 66.64 (42.82-267.63) | 68.96 (42.82-267.63) | 64.19 (44.50-117.53) | 0.870 |
| Potassium (mmol/L) | 3.99 (2.74-5.41) | 4.03 (2.80-5.41) | 3.89 (2.74-4.75) | 0.517 |
| Sodium (mmol/L) | 138.50 (133.50-145.50) | 137.95 (134.10-145.50) | 139.65 (133.50-145.20) | 0.210 |
| Prothrombin time (seconds) | 15.30 (12.70-20.40) | 15.30 (12.70-20.40) | 15.25 (12.00-18.90) | 0.774 |
| International normalized ratio | 1.24 (0.93-1.75) | 1.24 (0.99-1.75) | 1.24 (0.93-1.64) | 0.883 |
| Activated partial thromboplastin time (seconds) | 40.10 (19.80-53.80) | 40.10 (19.80-53.80) | 40.30 (27.50-50.80) | 0.961 |
| Child-Pugh score | 7.00 (5.00-10.00) | 7.00 (5.00-10.00) | 7.00 (5.00-13.00) | 0.259 |
| MELD score | 10.43 (6.43-18.00) | 10.52 (7.23-18.00) | 10.32 (6.43-15.58) | 0.676 |
| Portal vein thrombosis | 14 (25.0%) | 7 (25.0%) | 7 (25.0%) | 1.000 |
|
